Trials / Sponsors / Suzhou Ribo Life Science Co. Ltd.
Suzhou Ribo Life Science Co. Ltd.
Industry · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Partici Healthy Volunteers | Phase 1 | 2025-08-26 |
| Completed | A Study of RBD1016 in CHB Participants Chronic Hepatitis b | Phase 2 | 2023-10-11 |
| Completed | A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD70 Hyperlipemia | Phase 1 | 2023-05-30 |
| Active Not Recruiting | A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subje Healthy Volunteers | Phase 1 | 2023-03-21 |
| Completed | A Single and Multiple Ascending Doses Study to Evaluate the Safety and Pharmacokinetics of RBD5044 Health Volunteer | Phase 1 | 2022-11-10 |
| Completed | A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection Chronic Hepatitis B | Phase 1 | 2021-08-09 |
| Completed | A Single Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of RBD1016 Healthy Volunteers | Phase 1 | 2021-02-05 |